ISAL 2019 | AML research at Dana-Farber: updates from Richard Stone

Richard Stone

Ongoing acute leukemia research at Dana-Farber Cancer Institute, Boston, MA, is discussed here by Richard Stone, MD, at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany. Prof. Stone highlights immuno-oncology and targeted agents being investigated, including the inhibition of E-selectin.

Share this video